Latest DEF 14A proxy statements
NYSE
Allspring Utilities and High Income Fund filed an amended definitive proxy statement to correct a typographical error in shares outstanding and to solicit votes for its 2025 Annual Meeting of Shareholders.
NASDAQ
CNS Pharmaceuticals, Inc. will hold its Annual Meeting on November 17, 2025, seeking stockholder approval for key proposals including a significant increase in authorized shares and re-election of directors.
NASDAQ
Reading International, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 4, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
CPRT
Copart INCCopart, Inc. announced record fiscal year 2025 results with net income up 13.9% to $1.5 billion and total liquidity reaching $6 billion, alongside proposals for its upcoming annual meeting.
OQB
WORX
Scworx CORPSCWorx Corp. will hold its annual meeting on December 8, 2025, seeking shareholder approval for significant dilutive equity issuances, a substantial increase in authorized shares, and a new equity incentive plan.
NYSE
Allspring Utilities and High Income Fund is soliciting proxies for its Annual Meeting on December 1, 2025, primarily to elect three Class III Trustees.
NASDAQ
CRMD
Cormedix INCDEF: CorMedix Seeks Shareholder Approval for Key Governance, Equity, and Acquisition-Related Proposals
CorMedix Inc. calls a Special Meeting on November 10, 2025, to vote on critical proposals including removing an exchange cap for convertible notes and an acquisition, increasing its stock incentive plan, and ratifying past preferred stock amendments.
NASDAQ
Scienture Holdings, Inc. is seeking shareholder approval for critical proposals including a reverse stock split to maintain Nasdaq listing, a significant increase in authorized shares, and a potential future capital raise of up to $500 million.
AgriFORCE's strategic advisor and Hivemind's Matt Zhang detail AVAX One's vision to become the 'Berkshire Hathaway of the on-chain financial economy' through active digital asset management and fintech acquisitions.
NASDAQ
TSLA
Tesla, INCTesla is actively soliciting shareholder votes for its 2025 Annual Meeting, emphasizing support for Elon Musk's leadership and compensation proposals.
NASDAQ
Sunshine Biopharma Inc. announced its 2025 Annual Meeting of Shareholders to vote on director elections, auditor ratification, and an equity incentive plan amendment.
Alkermes plc announced its intent to acquire Avadel Pharmaceuticals plc, aiming to expand its neuroscience leadership and sleep disorder portfolio.
NYSE
Madison Square Garden Sports Corp. announces its 2025 Annual Meeting of Stockholders, detailing voting procedures and key proposals including director elections and auditor ratification.
NASDAQ
Reborn Coffee, Inc. filed a supplement to its proxy statement to correct a typographical error regarding its independent auditor for the upcoming annual meeting.
NASDAQ
InnovAge Holding Corp. announced its Annual Meeting of Stockholders for December 4, 2025, to vote on director elections and auditor ratification.
NASDAQ
STAAR Surgical Company and Alcon Research, LLC have agreed to adjourn the special meeting of stockholders to vote on their proposed merger until November 6, 2025.
NASDAQ
SCSC
Scansource, INCScanSource, Inc. announced its 2025 Annual Meeting of Shareholders to vote on director elections, executive compensation, and auditor ratification.
AMEX
AXIL
Axil Brands, INCAXIL BRANDS, INC. has submitted a Definitive Proxy Statement to the SEC under Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
BMRA
Biomerica INCBiomerica, Inc. has filed a Definitive Proxy Statement with the SEC, signaling an upcoming shareholder vote.
NASDAQ
1-800-FLOWERS.COM, Inc. announced its 2025 Annual Meeting of Stockholders, detailing proposals including director elections and a share plan amendment.
NASDAQ
FOXA
Fox CORPFox Corporation's Board of Directors strongly disagrees with Institutional Shareholder Services' recommendations regarding compensation committee members and governance issues, reaffirming its voting advice.
NYSE
WOLF
Wolfspeed, INCWolfspeed, Inc. has filed a Definitive Proxy Statement (Schedule 14A) with the U.S. Securities and Exchange Commission.
NASDAQ
Sunshine Biopharma Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, and vote on a significant increase in its equity incentive plan shares.
NASDAQ
InnovAge Holding Corp. announces its virtual 2025 Annual Meeting of Stockholders to elect three Class II directors and ratify Deloitte & Touche LLP as its independent auditor.
NYSE
Madison Square Garden Sports Corp. issues its 2025 proxy statement, outlining proposals for its virtual annual meeting, including director elections and executive compensation.
NASDAQ
Natural Alternatives International, Inc. is seeking stockholder approval for key proposals at its upcoming virtual annual meeting, including extending its equity incentive plan and increasing authorized shares.
AMEX
AXIL
Axil Brands, INCAXIL Brands, Inc. announces its 2025 Annual Meeting of Stockholders to elect Class II directors, ratify its independent auditor, and detail executive compensation and corporate governance.
AMEX
Evolution Petroleum Corporation announced its 2025 annual meeting of stockholders to be held on December 4, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
SCSC
Scansource, INCScanSource, Inc. reported strong free cash flow and gross profit growth with expanded margins in fiscal year 2025, despite a 6.7% decline in net sales due to a cautious technology spending environment.
NASDAQ
1-800-FLOWERS.COM, Inc. will hold its Annual Meeting on December 10, 2025, to elect directors, ratify auditors, and vote on increasing authorized shares for its long-term incentive plan, following a fiscal year with 0% executive annual incentive payouts due to missed financial targets.